| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $96.7M | +39.6% |
| SG&A Expense | $33.0M | +51.2% |
| Operating Income | -$129.7M | -42.4% |
| Pre-tax Income | -$109.0M | -42.8% |
| Income Tax | $355K | +258.6% |
| Net Income | -$109.4M | -43.1% |
| EPS (Basic) | -$3.96 | -15.8% |
| EPS (Diluted) | -$3.96 | -15.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $192.4M | -46.6% |
| Short-term Investments | $297.4M | — |
| Current Assets | $493.6M | +35.0% |
| Total Assets | $496.8M | +35.0% |
| Current Liabilities | $23.3M | +8.8% |
| Long-term Debt | $28.3M | — |
| Total Liabilities | $53.2M | +132.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.9M | -27.9% |
| Capital Expenditures | $505K | +467.4% |
| Investing Cash Flow | -$292.3M | — |
| Financing Cash Flow | $218.3M | -8.8% |
| Free Cash Flow | -$94.4M | -28.4% |
| Stockholders' Equity |
| $443.6M |
| +28.5% |